Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

GLORIA-AF Registry Program (Phase II/III - EU/EEA Member States)

This study is currently recruiting participants. (see Contacts and Locations)
Verified October 2016 by Boehringer Ingelheim
Information provided by (Responsible Party):
Boehringer Ingelheim Identifier:
First received: August 20, 2012
Last updated: October 3, 2016
Last verified: October 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: January 2020
  Estimated Primary Completion Date: January 2020 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):